COYA
Price
$6.05
Change
-$0.16 (-2.58%)
Updated
Sep 12 closing price
Capitalization
101.19M
53 days until earnings call
TRDA
Price
$5.28
Change
-$0.05 (-0.94%)
Updated
Sep 12 closing price
Capitalization
200.84M
59 days until earnings call
Interact to see
Advertisement

COYA vs TRDA

Header iconCOYA vs TRDA Comparison
Open Charts COYA vs TRDABanner chart's image
Coya Therapeutics
Price$6.05
Change-$0.16 (-2.58%)
Volume$190.1K
Capitalization101.19M
Entrada Therapeutics
Price$5.28
Change-$0.05 (-0.94%)
Volume$244.3K
Capitalization200.84M
COYA vs TRDA Comparison Chart in %
Loading...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COYA vs. TRDA commentary
Sep 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Hold and TRDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 14, 2025
Stock price -- (COYA: $6.05 vs. TRDA: $5.28)
Brand notoriety: COYA and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 231% vs. TRDA: 111%
Market capitalization -- COYA: $101.19M vs. TRDA: $200.84M
COYA [@Biotechnology] is valued at $101.19M. TRDA’s [@Biotechnology] market capitalization is $200.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • COYA’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both COYA and TRDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 4 TA indicator(s) are bullish while TRDA’s TA Score has 5 bullish TA indicator(s).

  • COYA’s TA Score: 4 bullish, 5 bearish.
  • TRDA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than COYA.

Price Growth

COYA (@Biotechnology) experienced а -3.51% price change this week, while TRDA (@Biotechnology) price change was -0.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.38%. For the same industry, the average monthly price growth was +7.84%, and the average quarterly price growth was +35.14%.

Reported Earning Dates

COYA is expected to report earnings on Nov 05, 2025.

TRDA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+1.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($201M) has a higher market cap than COYA($101M). COYA YTD gains are higher at: 5.585 vs. TRDA (-69.462). COYA has higher annual earnings (EBITDA): -22.59M vs. TRDA (-92.26M). TRDA has more cash in the bank: 354M vs. COYA (29.8M). TRDA has higher revenues than COYA: TRDA (79.5M) vs COYA (423K).
COYATRDACOYA / TRDA
Capitalization101M201M50%
EBITDA-22.59M-92.26M24%
Gain YTD5.585-69.462-8%
P/E RatioN/A10.26-
Revenue423K79.5M1%
Total Cash29.8M354M8%
Total DebtN/A54.7M-
TECHNICAL ANALYSIS
Technical Analysis
COYATRDA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 23 days ago
88%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 6 days ago
71%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MALRF22.31N/A
N/A
Mineral Resources Ltd.
KSTBF0.06N/A
N/A
Kestrel Gold, Inc.
CLRPF2.22N/A
N/A
Clarity Pharmaceuticals Ltd.
CMCAF11.40N/A
N/A
Capitalworks Emerging Markets Acquisition Corp
NVZMY63.07-0.28
-0.44%
NOVONESIS A S

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with KNSA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
-2.58%
KNSA - COYA
42%
Loosely correlated
+0.24%
GANX - COYA
37%
Loosely correlated
-3.49%
TRDA - COYA
36%
Loosely correlated
-0.94%
CRNX - COYA
34%
Loosely correlated
+0.80%
EYPT - COYA
33%
Poorly correlated
+0.15%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-0.94%
CRNX - TRDA
54%
Loosely correlated
+0.80%
XNCR - TRDA
51%
Loosely correlated
+1.18%
SYRE - TRDA
49%
Loosely correlated
-3.40%
RCUS - TRDA
49%
Loosely correlated
+0.17%
NRIX - TRDA
48%
Loosely correlated
-1.74%
More